PDB 5y9k
PDB Information
PDB | 5Y9K |
Method | X-RAY DIFFRACTION |
Host Organism | Escherichia coli |
Gene Source | Homo sapiens |
Primary Citation | BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus.
Nat Commun
|
Header | Protein Binding |
Released | 2017-08-25 |
Resolution | 1.900 |
CATH Insert Date | 03 Jun, 2018 |
PDB Images (7)
PDB Prints
PDB Chains (2)
Chain ID | Date inserted into CATH | CATH Status |
---|---|---|
H | 03 Jun, 2018 | Chopped |
L | 03 Jun, 2018 | Chopped |
CATH Domains (4)
Domain ID | Date inserted into CATH | Superfamily | CATH Status |
---|---|---|---|
5y9kH01 | 28 Jun, 2018 | Holding pen | |
5y9kH02 | 28 Jun, 2018 | 2.60.40.10 | Assigned |
5y9kL01 | 12 Jul, 2018 | 2.60.40.10 | Assigned |
5y9kL02 | 12 Jul, 2018 | 2.60.40.10 | Assigned |
UniProtKB Entries (0)
Accession | Gene ID | Taxon | Description |
---|